The SUVmax of HER2-positive breast cancer brain metastases was greater than the SUVmax of HER2-negative breast cancer brain metastases, although this difference was not statistically significant (14.82 vs 7.88, U = 32.50, p = 0.076). This evidence concerns the gene ERBB2 and breast carcinoma.